Information Provided By:
Fly News Breaks for March 3, 2020
TLRY
Mar 3, 2020 | 07:18 EDT
Benchmark analyst Mike Hickey lowered the firm's price target on Tilray to $12 from $28 after the company disappointed with Q4 sales and adjusted EBITDA that missed consensus, primarily reflecting declining bulk sales, operating expense growth and "an anemic retail buildout throughout Ontario and Quebec." However, he keeps a Buy rating on Tilray as he remains encouraged on the cannabis 2.0 launch of value-added products in Canada and thinks additional retail stores should provide a path toward positive adjusted EBITDA, Hickey tells investors.
News For TLRY From the Last 2 Days
There are no results for your query TLRY
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.